UNIGE document Scientific Article
previous document  unige:25030  next document
add to browser collection

Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors

Lorenzo, Petra I
Jimenez Moreno, Carmen M
Delgado, Irene
Cobo-Vuilleumier, Nadia
Gomez-Izquierdo, Lourdes
Garcia-Carbonero, Rocio
show hidden authors show all authors [1 - 10]
Published in Histochemistry and cell biology. 2011, vol. 136, no. 5, p. 595-607
Abstract The paired box transcription factor Pax8 is critical for development of the eye, thyroid gland as well as the urinary and reproductive organs. In adult, Pax8 overexpression is associated with kidney, ovarian and thyroid tumors and has emerged as a specific marker for these cancers. Recently, Pax8 expression was also reported in human pancreatic islets and in neuroendocrine tumors, identifying Pax8 as a novel member of the Pax family expressed in the pancreas. Herein, we sought to provide a comprehensive analysis of Pax8 expression during pancreogenesis and in adult islets. Immunohistochemical analysis using the most employed Pax8 polyclonal antibody revealed strong nuclear staining in the developing mouse pancreas and in mature human and mouse islets. Astonishingly, Pax8 mRNA in mouse islets was undetectable while human islets exhibited low levels. These discrepancies raised the possibility of antibody cross-reactivity. This premise was confirmed by demonstrating that the polyclonal Pax8 antibody also recognized the islet-enriched Pax6 protein both by Western blotting and immunohistochemistry. Thus, in islets polyclonal Pax8 staining corresponds mainly to Pax6. In order to circumvent this caveat, a novel Pax8 monoclonal antibody was used to re-evaluate whether Pax8 was indeed expressed in islets. Surprisingly, Pax8 was not detected in neither the developing pancreas or in mature islets. Reappraisal of pancreatic neuroendocrine tumors using this Pax8 monoclonal antibody exhibited no immunostaining as compared to the Pax8 polyclonal antibody. In conclusion, Pax8 is not expressed in the pancreas and cast doubts on the value of Pax8 as a pancreatic neuroendocrine tumor marker.
Keywords AnimalsAnimals, NewbornCell Nucleus/metabolismCross ReactionsEmbryo, Mammalian/metabolismGene Expression Regulation, DevelopmentalHumansIslets of Langerhans/embryology/metabolismKidney/embryology/metabolismLiver/embryology/metabolismMiceNeuroendocrine Tumors/metabolism/pathologyPaired Box Transcription Factors/genetics/metabolismPancreas/embryology/metabolismPancreatic Neoplasms/metabolism/pathologyRNA, Messenger/metabolismTumor Markers, Biological/metabolism
PMID: 21932072
Full text
Article (Published version) (2.5 MB) - public document Free access
Research group La transplantation d'îlots de Langerhans (623)
(ISO format)
LORENZO, Petra I et al. Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors. In: Histochemistry and cell biology, 2011, vol. 136, n° 5, p. 595-607. doi: 10.1007/s00418-011-0866-3 https://archive-ouverte.unige.ch/unige:25030

563 hits



Deposited on : 2013-01-07

Export document
Format :
Citation style :